Watchlist for week of June 20th - $FCSC, $LCI, $ALXA, $DRRX

FCSC - PDUFA 6/22 azficel-T, proposed brand name laViv®,”
LCI - PDUFA 6/23 Morphine Sulfate Oral Solution.
ALXA - new drug application (NDA) on AZ-004 (Staccato loxapine) for the treatment of acute agitation in patients with schizophrenia or bipolar disorder by the end of July 2011.
DRRX/PTIE - PDUFA 6/23 Remoxy

Holding FCSC & TTNP